Background: If the obese patient is willing to take part in a weight loss program that is medically supervised, intragastric balloon implantation has been found to be a safe, well-tolerated, and moderately cost minimally invasive surgery for weight loss. The present research is a retrospective investigation that looks at previously reported cases to determine if the patient, the technology, or the practitioner is to blame for major visceral complications. Aim: The goal of this research was to document the difficulties experienced by morbidly obese patients following the removal of a bio-enteric intragastric balloon. Patients and methods: Fifty morbidly obese patients (both sexes, ages 22-53 years) from the Suez Canal University Hospitals' Internal Medicine. Results: The patients' ages ranged from 22 to 53 years old, with a mean ±SD of 35.79 years. The average weight at the outset was 126.69±9.79 kilograms, or approximately 116.8±89.22 pounds. It was discovered that belching was the most often reported side effect, with 30 people (71.4% of the sample) reporting it. 18 patients (42.9%) reported feeling nauseous, 8 patients (19%) reported having bad breath, and 15 patients (35.7%) reported having reflux. Conclusion: Despite these concerns, hollow viscera complications are uncommon after a BIB or Orbera balloon implantation. By mandating training and accreditation programmes for bariatric endoscopic doctors and maintaining close supervision of obese patients undergoing balloon procedures, these complications can be avoided.